Latest Views & News

Advanced Oncotherapy – another spoof from the kings of spoofery as this time Exec Chairman buys

By Nigel Somerville, the Deputy Sheriff of AIM | Thursday 27 April 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Well that explains it then! Yesterday I noted my amazement that AIM-listed Advanced Oncotherapy (AVO) had issued yet another ramparoonie director share purchase RNS on Tuesday and that the shares had raced back above not only the all-important 27.5p mark, but above 30p. Now we know why: Executive Chairman Dr Michael Sinclair was in the market filling his boots with 200,000 shares  at an average price of 30.44p. Shame he didn’t pile in when the shares were hovering around the 26p mark so as to save himself a few quid.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

SAGA

The ongoing saga of woe at Saga

 

Quiz

The ShareProphets Sunday Pub Quiz #160

 

VCP

Gyrations at Victoria Carpets

 

MADE

GOTCHA: Made.com admits it is fucked

 

Bull

Stuff happens but we are not stuffed

 

Quiz

The ShareProphets Sunday Pub Quiz #159

 

OCDO

Challenges continue at Ocado

 

ICON

Iconic Labs – back from the dead?

 

PUR

Pure Gold – Pure Ramping!

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #158

 

ORCA

Buy Orcadian Energy